- Home
- WOK vs ACON Comparison
WOK vs ACON Comparison
Compare WOK & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WOK
- ACON
- Stock Information
- Founded
- WOK 2002
- ACON 2008
- Country
- WOK China
- ACON United States
- Employees
- WOK N/A
- ACON N/A
- Industry
- WOK
- ACON Retail: Computer Software & Peripheral Equipment
- Sector
- WOK
- ACON Technology
- Exchange
- WOK NYSE
- ACON Nasdaq
- Market Cap
- WOK 5.8M
- ACON 4.8M
- IPO Year
- WOK 2024
- ACON 2022
- Fundamental
- Price
- WOK $0.43
- ACON $7.64
- Analyst Decision
- WOK
- ACON Buy
- Analyst Count
- WOK 0
- ACON 2
- Target Price
- WOK N/A
- ACON $481.00
- AVG Volume (30 Days)
- WOK 225.4K
- ACON 75.1K
- Earning Date
- WOK 02-03-2025
- ACON 04-09-2025
- Dividend Yield
- WOK N/A
- ACON N/A
- EPS Growth
- WOK N/A
- ACON N/A
- EPS
- WOK N/A
- ACON N/A
- Revenue
- WOK $11,506,440.00
- ACON $45,724.00
- Revenue This Year
- WOK N/A
- ACON $251.35
- Revenue Next Year
- WOK N/A
- ACON N/A
- P/E Ratio
- WOK N/A
- ACON N/A
- Revenue Growth
- WOK N/A
- ACON N/A
- 52 Week Low
- WOK $0.36
- ACON $7.26
- 52 Week High
- WOK $8.45
- ACON $6,241.05
- Technical
- Relative Strength Index (RSI)
- WOK N/A
- ACON 33.40
- Support Level
- WOK N/A
- ACON $8.15
- Resistance Level
- WOK N/A
- ACON $8.30
- Average True Range (ATR)
- WOK 0.00
- ACON 1.25
- MACD
- WOK 0.00
- ACON 6.41
- Stochastic Oscillator
- WOK 0.00
- ACON 6.94
About WOK WORK MEDICAL TECHNOLOGY GROUP LTD
WORK Medical Technology Group Ltd is engaged in manufacturing and selling medical consumables through its wholly owned subsidiaries in the People's Republic of China. The Company's main products include medical face masks, tourniquets, airways, breathing circuits, intubation accessories, anesthesia kits, oxygen masks, suction sets, laryngoscope blades, KN95 masks, and other disposable medical devices, as well as medical equipment.
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.